Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 13 Dec 2022 for Reneo Pharmaceuticals, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Alejandro Dorenbaum: trading record in brief
Alejandro Dorenbaum, listed as senior executive, appears in our data through filings on OnKure Therapeutics, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 10 December 2021 to 12 August 2022, the count stands at 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 13 December 2022: a transaction, in OnKure Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Alejandro Dorenbaum
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
22,348 shares0Common StockSEC:0001209191-22-061032:0
30,000 shares0Common StockSEC:0001209191-21-069439:0
2 of 2 declarations
